TransCode Therapeutics, Inc. Common Stock (RNAZ) is a publicly traded Healthcare sector company. As of September 10, 2026, RNAZ trades at $1.70 with a market cap of $1.88M and a P/E ratio of -0.03. RNAZ moved +2.25% today. Year to date, RNAZ is -73.76%; over the trailing twelve months it is -84.59%. Its 52-week range spans $1.69 to $468.44. Rallies surfaces RNAZ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest RNAZ news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $1.70 |
| Market Cap | $1.88M |
| P/E Ratio | -0.03 |
| EPS | $-52.59 |
| Dividend Yield | 0.00% |
| 52-Week High | $468.44 |
| 52-Week Low | $1.69 |
| Volume | 24.69K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-34.66M |
| Gross Margin | 0.00% |
RNAZ analyst coverage data. Average price target: $0.00.